Inventor · disambiguated record
Mark A. Bernard
Also filed as: BERNARD MARK · BERNARD MARK A · BERNARD MARK ANTHONY
7 granted patents·5 pending applications·160 citations·filing 2001–2022
87Inventor score
Files withOMNIOME INC5GLENMARK PHARMACEUTICALS SA2PACIFIC BIOSCIENCES CALIFORNIA INC2LAZARIDES ELIAS1NUREVELATION LLC1
Top patents by PatentIndex Score
12 records- 0197US10246744B2Method and system for sequencing nucleic acidsOMNIOME INC·Filed 2017·Granted Apr 2, 2019·70 cites·20 claims
- 0296US11499185B2Nucleic acid sequencing methods and systemsOMNIOME INC·Filed 2018·Granted Nov 15, 2022·19 cites·24 claims
- 0396US10443098B2Method and system for sequencing nucleic acidsOMNIOME INC·Filed 2017·Granted Oct 15, 2019·28 cites·19 claims
- 0496US10077470B2Nucleic acid sequencing methods and systemsOMNIOME INC·Filed 2015·Granted Sep 18, 2018·25 cites·69 claims
- 0585US7807794B2Anti-α2 integrin antibodies and their usesGLENMARK PHARMACEUTICALS SA·Filed 2006·Granted Oct 5, 2010·11 cites·16 claims
- 0684US11168364B2Method and system for sequencing nucleic acidsOMNIOME INC·Filed 2019·Granted Nov 9, 2021·1 cites·21 claims
- 0779US8759009B2Anti-alpha2 integrin antibodies and their usesLAZARIDES ELIAS·Filed 2010·Granted Jun 24, 2014·6 cites·36 claims
- 0876US2024035082A1Nucleic acid sequencing methods and systemsPACIFIC BIOSCIENCES CALIFORNIA INC·Filed 2022·Application pending·0 cites
- 0975US2022162690A1Method and system for sequencing nucleic acidsPACIFIC BIOSCIENCES CALIFORNIA INC·Filed 2021·Application pending·0 cites
- 1054US2014341892A1Anti-alpha2 integrin antibodies and their usesGLENMARK PHARMACEUTICALS SA·Filed 2014·Application pending·0 cites
- 1151US2002002531A1System and method for facilitating a transaction through binding comparison shopping using a communications networkFiled 2001·Application pending·0 cites
- 1244US2022062190A1Therapeutic Agent and Nutraceutical Compositions And Methods for Making and Using SameNUREVELATION LLC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark A. Bernard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →